Suppr超能文献

对由DSM 18113组成的、用于所有动物物种的饲料添加剂进行重新授权评估(先锋良种国际公司)。

Assessment of the feed additive consisting of  DSM 18113 for all animal species for the renewal of its authorisation (Pioneer Hi-Bred International, Inc.).

作者信息

Bampidis Vasileios, Azimonti Giovanna, Bastos Maria de Lourdes, Christensen Henrik, Durjava Mojca, Dusemund Birgit, Kouba Maryline, López-Alonso Marta, López Puente Secundino, Marcon Francesca, Mayo Baltasar, Pechová Alena, Petkova Mariana, Ramos Fernando, Villa Roberto Edoardo, Woutersen Ruud, Anguita Montserrat, Bozzi Cionci Nicole, Brozzi Rosella, Galobart Jaume, García-Cazorla Yolanda, Innocenti Matteo L, Revez Joana

出版信息

EFSA J. 2024 May 24;22(5):e8783. doi: 10.2903/j.efsa.2024.8783. eCollection 2024 May.

Abstract

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of (formerly ) DSM 18113 as a technological additive (functional group: silage additive) for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the additive remains safe for all animal species, consumers and the environment. Regarding user safety, the Panel concluded that owing to the nature of the additive, DSM 18113 should be considered a potential skin and respiratory sensitiser, and that any exposure through the skin and respiratory tract is considered a risk. The Panel could not conclude on the eye irritation potential of the additive due to the lack of data. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.

摘要

应欧盟委员会的要求,欧洲食品安全局(EFSA)被要求就重新评估DSM 18113(原 )作为所有动物种类的技术添加剂(功能类别:青贮饲料添加剂)的申请提供科学意见。申请人已提供证据证明目前市场上的添加剂符合现有授权条件。欧洲食品安全局动物饲料添加剂和产品或物质专家小组(FEEDAP)得出结论,该添加剂对所有动物种类、消费者和环境仍然是安全的。关于使用者安全,专家小组得出结论,由于添加剂的性质,DSM 18113应被视为潜在的皮肤和呼吸道致敏剂,通过皮肤和呼吸道的任何接触都被视为有风险。由于缺乏数据,专家小组无法就该添加剂的眼刺激可能性得出结论。在授权续期的背景下,没有必要评估该添加剂的功效。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验